Physician

Internal Medicine

Timothy Hofer practices Internal Medicine. He researched medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care Timothy Hofer is a published doctor as well. He has 99 publications published. The latest was: Interpreting risk-adjusted length of stay patterns for VA hospitals.

Publications

---

• Assessing the Caprini Score for Risk Assessment of Venous Thromboembolism in Hospitalized Medical Patients.
• Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.
• Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study.
• Effects of Performance Measure Implementation on Clinical Manager and Provider Motivation.
• The Use of Multiple Qualitative Methods to Characterize Communication Events Between Physicians and Nurses.
• Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans.
• Preventing catheter-associated urinary tract infection in the United States: a national comparative study.
• Use of health IT for higher-value critical care.
• Preventing Hospital-Acquired Infections: A National Survey of Practices Reported by U.S. Hospitals in 2005 and 2009.
• Commentary on Sharek: adverse events and errors-important to differentiate and difficult to measure.
• Infrastructure for quality transformation: measurement and reporting in veterans administration intensive care units.
• Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer.
• Patient-provider concordance in the prioritization of health conditions among hypertensive diabetes patients.
• Coordinating cancer care: patient and practice management processes among surgeons who treat breast cancer.
• Commentary: What's in a name? Statistical discrimination and disparities research.
• First Things First: Difficulty with Current Medications Is Associated With Patient Willingness to Add New Ones.
• More than a pain in the neck: how discussing chronic pain affects hypertension medication intensification.
• Latinas and breast cancer outcomes: population-based sampling, ethnic identity, and acculturation assessment.
• Treatment decisions for complex patients: differences between primary care physicians and midlevel providers.
• When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
• The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure.
• Veterans Affairs intensive care unit risk adjustment model: validation, updating, recalibration.
• A multicenter qualitative study on preventing hospital-acquired urinary tract infection in US hospitals.
• Preventing hospital-acquired urinary tract infection in the United States: a national study.
• Quality by any other name?: a comparison of three profiling systems for assessing health care quality.
• Area socioeconomic status and mortality after coronary artery bypass graft surgery: the role of hospital volume.
• Overestimating outcome rates: statistical estimation when reliability is suboptimal.
• Use of central venous catheter-related bloodstream infection prevention practices by US hospitals.
• Physician-level P4P--DOA? Can quality-based payment be resuscitated?
• Patterns and correlates of patient referral to surgeons for treatment of breast cancer.
• Adult fat intake associated with the presence of children in households: findings from NHANES III.
• Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.
• Translating infection prevention evidence into practice using quantitative and qualitative research.
• Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature.
• Reporting clinical trial results to inform providers, payers, and consumers.
• Sins of omission: getting too little medical care may be the greatest threat to patient safety.
• Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens.
• Variation in outcomes in Veterans Affairs intensive care units with a computerized severity measure.
• Impact of patient risk on the hospital volume-outcome relationship in coronary artery bypass grafting.
• Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.
• Barriers to constraining health care cost growth.
• When there is too much to do: how practicing physicians prioritize among recommended interventions.
• Quality improvement initiatives: issues in moving from diabetes guidelines to policy.
• When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make?
• Use of critical pathways to improve efficiency: a cautionary tale.
• Building a better quality measure: are some patients with 'poor quality' actually getting good care?
• Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.
• Does full disclosure of medical errors affect malpractice liability? The jury is still out.
• Accepting critically ill transfer patients: adverse effect on a referral center's outcome and benchmark measures.
• Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities.
• Comparing clinical automated, medical record, and hybrid data sources for diabetes quality measures.
• Are bad outcomes from questionable clinical decisions preventable medical errors? A case of cascade iatrogenesis.
• Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle.
• Hepatic oxidative stress during aging: effects of 8% long-term calorie restriction and lifelong exercise.
• A method to determine RNA and DNA oxidation simultaneously by HPLC-ECD: greater RNA than DNA oxidation in rat liver after doxorubicin administration.
• DNA oxidative damage and strand breaks in young healthy individuals: a gender difference and the role of life style factors.
• Evaluation of sex differences on mitochondrial bioenergetics and apoptosis in mice.
• Increased iron content and RNA oxidative damage in skeletal muscle with aging and disuse atrophy.
• Comparison of lifelong and late life exercise on oxidative stress in the cerebellum.
• Molecular mechanisms of life- and health-span extension: role of calorie restriction and exercise intervention.
• The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation.
• Hydrogen peroxide causes greater oxidation in cellular RNA than in DNA.
• Cellular background level of 8-oxo-7,8-dihydro-2''-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequen...
• Optimization of the workup procedure for the analysis of 8-oxo-7,8-dihydro-2'-deoxyguanosine with electrochemical detection.
• Inter-rater reliability of case-note audit: a systematic review.
• Who bounces back? Physiologic and other predictors of intensive care unit readmission.
• Reduction of oxidation during the preparation of DNA and analysis of 8-hydroxy-2'-deoxyguanosine.
• The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
• 32P-postlabeling high-performance liquid chromatography (32P-HPLC) adapted for analysis of 8-hydroxy-2''-deoxyguanosine.
• Discussion between reviewers does not improve reliability of peer review of hospital quality.
• Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.
• Automated computerized intensive care unit severity of illness measure in the Department of Veterans Affairs: preliminary results. SISVistA Investigators. Scrutiny of ...
• Use of community versus individual socioeconomic data in predicting variation in hospital use.
• Are physicians aware of which of their patients have indwelling urinary catheters?
• [32P]ATP mediates formation of 8-hydroxy-2''-deoxyguanosine from 2''-deoxyguanosine, a possible problem in the 32P-postlabeling assay.
• Methodological considerations and factors affecting 8-hydroxy-2-deoxyguanosine analysis.
• Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
• Estimated benefits of glycemic control in microvascular complications in type 2 diabetes.
• Breast cancer screening in the United States and Canada, 1994: socioeconomic gradients persist.
• The role of hospital volume in coronary artery bypass grafting: is more always better?
• Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures.
• Interpreting risk-adjusted length of stay patterns for VA hospitals.
• Validating quality indicators for hospital care.
• Hospital utilization in Ontario and the United States: the impact of socioeconomic status and health status.
• Accuracy of risk-adjusted mortality rate as a measure of hospital quality of care.
• Knowledge of blood pressure targets among patients with diabetes.
• An epistemology of patient safety research: a framework for study design and interpretation. Part 1. Conceptualising and developing interventions.
• An epistemology of patient safety research: a framework for study design and interpretation. Part 2. Study design.
• An epistemology of patient safety research: a framework for study design and interpretation. Part 3. End points and measurement.
• An epistemology of patient safety research: a framework for study design and interpretation. Part 4. One size does not fit all.
• Healthy behaviors among women in the United States and Ontario: the effect on use of preventive care.
• Measuring physician attitudes toward cost, uncertainty, malpractice, and utilization review.
• Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States.
• Identifying poor-quality hospitals. Can hospital mortality rates detect quality problems for medical diagnoses?
• Can early re-admission rates accurately detect poor-quality hospitals?
• Physician use in Ontario and the United States: The impact of socioeconomic status and health status.
• Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer.
• Barriers to following dietary recommendations in Type 2 diabetes.

Schools

---

• University of California At San Francisco

Doctors Specialties

---

• Internal Medicine

Accepted Insurances

---

Education

---

• University of California San Francisco School of Medicine

Hospital

---

• University of Michigan Hospitals and Health Centers

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. James L. Baldwin, MD
	Dr. Dina H. Hafez, MD
	Dr. Rishi Chanderraj, MD
	Dr. Jennifer P. Waugh, MD
	Dr. Jagan M. Kakarala, MD
	Dr. Jessica X. Yu, MD
	Dr. Ellen K. Hummel, MD This Doctor is OpenDoctor Recommended.
	Dr. Rina Verma, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog